8 months ago
GH
AnalystsDan LeonardDan Leonard's Stock Forecasts
AnalystsDan Leonard
Analyst Ranking
Top 10%
#470 out of 4867 analysts
Average Return
+7.11%
Win Rate
53%73 out of 139
Risk vs Reward
Poor
Good
Dan Leonard's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Charles River Laboratories International IncCRL | +121.52% | $129.99 | $287.96 | 2020-03-29 - 2021-03-30 | Strong Buy |
Natera IncNTRA | +95.26% | $51.02 | $99.62 | 2023-08-03 - 2024-08-02 | Buy |
Hologic IncHOLX | +93.01% | $37.77 | $72.90 | 2020-04-06 - 2021-04-07 | Strong Buy |
Labcorp Holdings IncLH | +92.15% | $131.95 | $253.54 | 2020-03-29 - 2021-03-30 | Strong Buy |
Natera IncNTRA | +86.58% | $51.21 | $95.55 | 2023-05-09 - 2024-05-09 | Buy |
Dan Leonard Analyst Color
Get additional color on Dan Leonard's coverage of popular stocks
3 years ago
RVTY
3 years ago
HOLX
3 years ago
DHR
3 years ago
LH
3 years ago
IQV
Dan Leonard's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Thermo Fisher Scientific IncTMO | 12 | Strong Buy | $500.00 | +16.95% | Maintains | 6 days ago |
Danaher CorpDHR | 13 | Strong Buy | $240.00 | +20.65% | Maintains | 8 days ago |
10x Genomics IncTXG | 4 | Hold | $14.00 | +67.06% | Maintains | 3 months ago |
Iqvia Holdings IncIQV | 13 | Strong Buy | $255.00 | +66.18% | Maintains | 3 months ago |
Avantor IncAVTR | 6 | Hold | $25.00 | +97.01% | Downgrades | 3 months ago |
Charles River Laboratories International IncCRL | 6 | Hold | $185.00 | +57.73% | Downgrades | 3 months ago |
Bruker CorpBRKR | 6 | Hold | $66.00 | +65.66% | Assumes | 5 months ago |
Cryoport IncCYRX | 2 | Hold | $9.00 | +60.14% | Maintains | 6 months ago |
Medpace Holdings IncMEDP | 1 | Hold | $350.00 | +14.25% | Downgrades | 7 months ago |
Certara IncCERT | 9 | Strong Buy | $16.00 | +15.19% | Upgrades | 7 months ago |
Guardant Health IncGH | 8 | Strong Buy | $40.00 | -19.24% | Maintains | 8 months ago |
Bio Rad Laboratories IncBIO | 16 | Strong Buy | $385.00 | +58.88% | Maintains | a year ago |
Revvity IncRVTY | 11 | Hold | $125.00 | N/A | Downgrades | a year ago |
Bio Techne CorpTECH | 9 | Strong Buy | $80.00 | N/A | Initiates Coverage On | a year ago |
Fulgent Genetics IncFLGT | 4 | Hold | $35.00 | N/A | Initiates Coverage On | a year ago |
Agilent Technologies IncA | 16 | Buy | $150.00 | N/A | Maintains | 2 years ago |
Illumina IncILMN | 10 | Hold | $200.00 | N/A | Maintains | 2 years ago |
Maravai Lifesciences Holdings IncMRVI | 6 | Hold | $11.00 | N/A | Maintains | 2 years ago |
Natera IncNTRA | 7 | Buy | $70.00 | N/A | Reiterates | 2 years ago |
Exact Sciences CorpEXAS | 9 | Hold | $90.00 | N/A | Maintains | 2 years ago |
Adaptive Biotechnologies CorpADPT | 2 | Sell | $7.00 | N/A | Reiterates | 2 years ago |
Waters CorpWAT | 8 | Hold | $345.00 | N/A | Initiates Coverage On | 3 years ago |
Icon PLCICLR | 5 | Hold | $260.00 | N/A | Initiates Coverage On | 3 years ago |
Invitae CorpNVTAQ | 3 | Sell | $1.00 | N/A | Initiates Coverage On | 3 years ago |
Quest Diagnostics IncDGX | 9 | Hold | $145.00 | N/A | Maintains | 3 years ago |
Hologic IncHOLX | 10 | Strong Buy | $90.00 | N/A | Maintains | 3 years ago |
Qiagen NvQGEN | 2 | Hold | $61.80 | N/A | Maintains | 3 years ago |
Labcorp Holdings IncLH | 7 | Strong Buy | $340.00 | N/A | Maintains | 3 years ago |
Stevanato Group SpaSTVN | 1 | Strong Buy | $24.00 | N/A | Initiates Coverage On | 4 years ago |
Mettler Toledo International IncMTD | 6 | Hold | $1,500.00 | N/A | Maintains | 4 years ago |
Biora Therapeutics IncBIOR | 2 | Strong Sell | $5.00 | N/A | Downgrades | 4 years ago |
Myriad Genetics IncMYGN | 7 | Hold | $43.00 | N/A | Maintains | 6 years ago |
Luminex CorpLMNX | 2 | Hold | N/A | N/A | Upgrades | 7 years ago |
Genomic Health IncGHDX | 1 | Hold | $31.00 | N/A | Initiates Coverage On | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.